Estimated post-tax NPV (8% discount rate) of EUR 1,194m (USD1 1,246m). Estimated post-tax IRR of 22.3%. Estimated annual EBITDA of EUR 293m (USD 305m); after-tax annual cash flow of EUR 188m (USD 199m). Estimated average battery-grade lithium hydroxide (LHM) prices of 31,771 USD/t, and…

SHANGHAI, May 15, 2023 /PRNewswire/ — Rona Therapeutics, Inc (“Rona”) and Keymed Biosciences (“Keymed”, HKEX: 02162), today announced a collaboration to jointly discover and develop first-in-class siRNA therapeutics for Glomerulonephritis (also referred as severe kidney diseases). The…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.